Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Relationships of PAI-1 gene polymorphisms with the efficacy of ustekinumab in the treatment of patients with Crohn disease].

Zhonghua yi xue za zhi - 26 May 2026

Xu J Y, Xiong Y J, Lan R T, Chen R, Zhu X Y, Jiang Y

Abstract excerpt

Objective: To explore the relationships of plasminogen activator inhibitor 1 (PAI-1) gene polymorphisms with the efficacy of ustekinumab (UST) in the treatment of patients with Crohn disease (CD). Methods: The patients with active CD who received UST treatment at the Department of Gastroenterology, the Second Affiliated Hospital of Wenzhou Medical University between January 2021 and January 2025 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Crohn Disease
Share to Genotype
Share to Plasminogen Activator Inhibitor 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Genetic

Share to Polymorphism, Single Nucleotide

Share to Treatment Outcome

Source

Identifiers

PMID: 42161612
DOI: 10.3760/cma.j.cn112137-20251217-03341

Genes

UST

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Relationships of PAI-1 gene polymorphisms with the efficacy of ustekinumab in the treatment of patients with Crohn disease].PMID 42161612Read ↗

[Association of microRNA gene polymorphisms with risk, clinicopathological characteristics and therapeutical efficacy among Chinese patients with Crohn's disease].Semantic proximity Read ↗

[Association of Toll-like receptor 5 gene polymorphism with the clinical efficacy of ustekinumab in patients with Crohn's disease].Semantic proximity Read ↗

[Relationships of interleukin-7 receptor gene polymorphisms with the risk of Crohn's disease and the efficacy of infliximab].Semantic proximity Read ↗

[Association of ITGA4 and ICAM-1 gene polymorphisms with the risk and clinicopathological characteristics of Crohn's disease].Semantic proximity Read ↗

[The associations of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene polymorphisms with the risk of Crohn's disease in Chinese patients].Semantic proximity Read ↗

What is the impact of plasminogen activator inhibitor type 1 (PAI-1) gene polymorphism on gynecological malignancies: a retrospective studySemantic proximity Read ↗

Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three yearsSemantic proximity Read ↗

The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease.Semantic proximity Read ↗

Comparative Effectiveness and Safety of Ustekinumab versus Anti–TNF Therapy in Crohn Disease: A Systematic ReviewSemantic proximity Read ↗

Association of plasminogen activator inhibitor-1 gene polymorphism with inflammatory bowel disease in Iranian Azeri Turkish patients.Semantic proximity Read ↗

Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumorsSemantic proximity Read ↗

[Tumor necrosis factor-related apoptosis-inducing ligand gene polymorphism and its plasma phenotype in relation to Crohn's disease].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.